# A Novel TBI Free Conditioning Protocol for Haploidentical Transplant in Acquired Aplastic Anemia:

> **NCT03955601** · PHASE2 · UNKNOWN · sponsor: **National Institute of Blood and Marrow Transplant (NIBMT), Pakistan** · enrollment: 30 (estimated)

## Conditions studied

- Aplastic Anemia Idiopathic

## Interventions

- **DRUG:** Haploidentical HSCT using TBI free regimen, ''ATG'' with ''Post transplant cyclophosphamide''

## Key facts

- **NCT ID:** NCT03955601
- **Lead sponsor:** National Institute of Blood and Marrow Transplant (NIBMT), Pakistan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-12
- **Primary completion:** 2020-12-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2020-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03955601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03955601, "A Novel TBI Free Conditioning Protocol for Haploidentical Transplant in Acquired Aplastic Anemia:". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03955601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*